中图分类号:
R969.1
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] WALLEMACQ P E, REDING R. FK506 (tacrolimus), a novel immunosuppressant in organ transplantation: Clinical, biomedical, and analytical aspects . Clin Chem, 1993, 39(11 Pt 1): 2219-2228.
[2] VINCENTI F, JENSIK S C, FILO R S, et al. A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: Evidence for improved allograft survival at five years . Transplantation, 2002, 73(5): 775-782.
[3] LERUT J, MATHYS J, VERBAANDERT C, et al. Tacrolimus monotherapy in liver transplantation: One-year results of a prospective, randomized, double-blind, placebo-controlled study . Ann Surg, 2008, 248(6): 956-967.
[4] PIRSCH J D, MILLER J, DEIERHOI M H, et al. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group . Transplantation, 1997, 63(7): 977-983.
[5] JENSIK S C. Tacrolimus (FK 506) in kidney transplantation: Three-year survival results of the US multicenter, randomized, comparative trial. FK 506 Kidney Transplant Study Group . Transplant Proc, 1998, 30(4): 1216-1218.
[6] VINCENTI F. Tacrolimus (FK 506) in kidney transplantation: Five-year survival results of the U.S. multicenter, randomized, comparative trial . Transplant Proc, 2001, 33(1-2): 1019-1020.
[7] XIA D Y, LIU L, GUO T, et al. Pharmacokinetics of tacrolimus in renal transplant recipients . Chin Pharm J (中国药学杂志), 2004, 39(10): 62-64.
[8] JAIN A, BRODY D, HAMAD I, et al. Conversion to neoral for neurotoxicity after primary adult liver transplantation under tacrolimus . Transplantation, 2000, 69(1): 172-176.
[9] GU J, ZHANG C Y, LI Y Z. Advance in therapeutic drug monitoring of tacrolimus. Chin Pharm J(中国药学杂志), 2007, 42(01): 6-9.
[10]STAATZ C E, WILLIS C, TAYLOR P J, et al. Population pharmacokinetics of tacrolimus in adult kidney transplant recipients . Clin Pharmacol Ther, 2002, 72(6): 660-669.
ANTIGNAC M, BARROU B, FARINOTTI R, et al. Population pharmacokinetics and bioavailability of tacrolimus in kidney transplant patients . Br J Clin Pharmacol, 2007, 64(6): 750-757.
ZHAO W, ELIE V, ROUSSEY G, et al. Population pharmacokinetics and pharmacogenetics of tacrolimus in de novo pediatric kidney transplant recipients . Clin Pharmacol Ther, 2009, 86(6): 609-618.
BENKALI K, PREMAUD A, PICARD N, et al. Tacrolimus population pharmacokinetic-pharmacogenetic analysis and Bayesian estimation in renal transplant recipients . Clin Pharmacokinet, 2009, 48(12): 805-816.
VELICKOVIC-RADOVANOVIC R, CATIC-DJORDJEVIC A, MILOVANOVIC J R, et al. Population pharmacokinetics of tacrolimus in kidney transplant patients . Int J Clin Pharmacol Ther, 2010, 48(6): 375-382.
BENKALI K, ROSTAING L, PREMAUD A, et al. Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in renal transplant recipients on a new once-daily formulation . Clin Pharmacokinet, 2010, 49(10): 683-692.
ZHANG G M, LI L, CHEN W Q, et al. Population pharmacokinetics of tacrolimus in Chinese renal transplant patients . Acta Pharm Sin (药学学报), 2008, 43(07): 695-701.
CHEN X Q, ZHOU L, SU Y, et al. Neural network and its applications in pharmacokinetics and pharmacodynamics . J Southwest Univ Nats (Nat Sci Ed) (西南民族学院学报:自然科学版), 2001, 27(01): 84-87.
REN B, HE Q Y, XU Q, et al. Prediction of mycophenolic acid exposure in renal transplantation recipients by artificial neural network . Acta Pharm Sin (药学学报), 2009, 44(12): 1397-1401.
GOREN S, KARAHOCA A, ONAT F Y, et al. Prediction of cyclosporine A blood levels: An application of the adaptive-network-based fuzzy inference system (ANFIS) in assisting drug therapy . Eur J Clin Pharmacol, 2008, 64(8): 807-814.
LI C P, ZHI X N, LIU X H, et al. Combining the best subset method with the Akike Information Criterion to build Logistic Regression in predictiving peripheral neuropathy in Type 2 Diabetes Mellitus . Chin J Health Stat (中国卫生统计), 2010, 127(06): 594-597.
SHEINER L B, BEAL S L. Some suggestions for measuring predictive performance . J Pharmacokinet Biopharm, 1981, 9(4): 503-512.
XU F, ZHAI S D, HU Y F. Molecular mechanism for drug-drug interaction related to tacrolimus . Chin Pharm J(中国药学杂志), 2007, 42(13): 965-968.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}